Interstitial lung disease before and after COVID-19: a double threat?

Pre-existing ILD and pulmonary fibrosis increases the risk to manifest severe COVID-19. Residual interstitial lung changes and sequelae have been observed in COVID-19 survivors. A closer and standardised long-term follow-up of these patients is needed. https://bit.ly/3jWBPCG

Detalles Bibliográficos
Autores principales: Valenzuela, Claudia, Waterer, Grant, Raghu, Ganesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Editorials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637181/
https://www.ncbi.nlm.nih.gov/pubmed/34857587
http://dx.doi.org/10.1183/13993003.01956-2021
_version_ 1784608691168739328
author Valenzuela, Claudia
Waterer, Grant
Raghu, Ganesh
author_facet Valenzuela, Claudia
Waterer, Grant
Raghu, Ganesh
author_sort Valenzuela, Claudia
collection PubMed
description Pre-existing ILD and pulmonary fibrosis increases the risk to manifest severe COVID-19. Residual interstitial lung changes and sequelae have been observed in COVID-19 survivors. A closer and standardised long-term follow-up of these patients is needed. https://bit.ly/3jWBPCG
format Online
Article
Text
id pubmed-8637181
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-86371812021-12-03 Interstitial lung disease before and after COVID-19: a double threat? Valenzuela, Claudia Waterer, Grant Raghu, Ganesh Eur Respir J Editorials Pre-existing ILD and pulmonary fibrosis increases the risk to manifest severe COVID-19. Residual interstitial lung changes and sequelae have been observed in COVID-19 survivors. A closer and standardised long-term follow-up of these patients is needed. https://bit.ly/3jWBPCG European Respiratory Society 2021-12-02 /pmc/articles/PMC8637181/ /pubmed/34857587 http://dx.doi.org/10.1183/13993003.01956-2021 Text en Copyright ©The authors 2021. https://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org (mailto:permissions@ersnet.org)
spellingShingle Editorials
Valenzuela, Claudia
Waterer, Grant
Raghu, Ganesh
Interstitial lung disease before and after COVID-19: a double threat?
title Interstitial lung disease before and after COVID-19: a double threat?
title_full Interstitial lung disease before and after COVID-19: a double threat?
title_fullStr Interstitial lung disease before and after COVID-19: a double threat?
title_full_unstemmed Interstitial lung disease before and after COVID-19: a double threat?
title_short Interstitial lung disease before and after COVID-19: a double threat?
title_sort interstitial lung disease before and after covid-19: a double threat?
topic Editorials
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637181/
https://www.ncbi.nlm.nih.gov/pubmed/34857587
http://dx.doi.org/10.1183/13993003.01956-2021
work_keys_str_mv AT valenzuelaclaudia interstitiallungdiseasebeforeandaftercovid19adoublethreat
AT waterergrant interstitiallungdiseasebeforeandaftercovid19adoublethreat
AT raghuganesh interstitiallungdiseasebeforeandaftercovid19adoublethreat

Ejemplares similares